$80K - $100K*
Atreca's IRC technology identifies anti-tumor human antibodies in a highly accurate and precise fashion. Our goal is to apply this technology to elucidate and characterize novel tumor targets and associated biologic processes that were selected for attack by the patient's immune system. In this position, the successful candidate will apply their skills and expertise in protein biochemistry to perform epitope characterization as related to tumor specificity of our novel targets. These will include characterizing tumor-specific post-translational modifications, complexes and expression. The successful candidate will have extensive experience in molecular biology and protein biochemistry and experience in optimizing conditions to move studies forward to reach project goals. As a successful candidate you will enjoy working in a fast-paced environment and collaborating across groups including in vivo pharmacology and translational sciences.
Primary Duties and Responsibiliti
Valid through: 2020-5-13
$80K - $100K
18 days ago